- Home
- OGI
as 01-17-2025 4:00pm EST
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
| Founded: | 2013 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 200.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 710.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.31 - $2.91 | Next Earning Date: | 02-11-2025 |
| Revenue: | $118,317,480 | Revenue Growth: | 0.69% |
| Revenue Growth (this year): | 57.65% | Revenue Growth (next year): | 10.93% |
Latest Organigram Holdings Inc. News
OGI Breaking Stock News: Dive into OGI Ticker-Specific Updates for Smart Investing
Insider Monkey
19 days ago
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts?
Business Wire
a month ago
Organigram Reports Fourth Quarter and Fiscal 2024 Results
GuruFocus.com
a month ago
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Motley Fool
a month ago
Organigram (OGI) Q4 2024 Earnings Call Transcript
Associated Press Finance
a month ago
OrganiGram: Fiscal Q4 Earnings Snapshot
TipRanks
a month ago
Organigram Acquires Motif Labs, Becomes Canada’s Largest Cannabis Company
Business Wire
a month ago
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
Market Exclusive
a month ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Compare OGI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OGI Organigram Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.